Global Lisdexamfetamine Drug Market Growth 2026-2032
The global Lisdexamfetamine Drug market size is predicted to grow from US$ 3733 million in 2025 to US$ 6371 million in 2032; it is expected to grow at a CAGR of 8.1% from 2026 to 2032.
Lisdexamfetamine is a central nervous system stimulant and a prodrug of dextroamphetamine, formed by combining dextroamphetamine with the amino acid lysine. It is primarily prescribed for the treatment of attention deficit hyperactivity disorder (ADHD) in children, adolescents, and adults, as well as for moderate to severe binge eating disorder in adults. Administered orally, it is metabolized into dextroamphetamine, with onset of action within about two hours and effects lasting up to 14 hours. In 2024, the global sales volume of lisdexamfetamine was 7.76 million units, with an average price of USD 459.9 per unit. The average gross margin of companies was 42.5%, and the annual production capacity of a single production line was 500,000 units.
Regional market landscape
The global market shows clear regional concentration with North America holding 45.2% of total volume, Europe 28.7%, Asia-Pacific 18.3%, Latin America 5.1%, and Middle East & Africa 2.7%; by formulation capsules represent 62.0% of global share, tablets 30.5% and oral solutions 7.5%, while distribution channels are split with hospitals and clinics accounting for 41.3% of demand, retail pharmacies 48.6% and other channels 10.1%, and these fixed regional and channel weights materially influence supply-chain planning, inventory strategy and market entry prioritization.
Key manufacturers and industry competition
The production and supply landscape for lisdexamfetamine is defined by competition between the originator and multiple generic manufacturers: Takeda remains the principal originator with substantial global rights, while generic producers have secured approvals and rapidly scaled capacity across markets; upstream, key chemical raw materials and API intermediates are typically supplied by large chemical firms and CDMOs (for example BASF, Lonza, Evonik and similar suppliers) together with packaging and capsule shell vendors, and downstream distribution is handled by hospitals, wholesalers and retail pharmacy networks, so due diligence must examine originator and generic capacity expansion plans, API sourcing and alternate supply channels, and downstream concentration to assess pricing elasticity and shortage risk.
Technology trends and innovation direction
Current technical trends emphasize improving formulation stability and content uniformity, refining bioequivalence and extended-release evaluation methods, and integrating tighter quality control and digital traceability into manufacturing; generics and CDMOs are reducing costs and improving consistency via process scale-up, continuous flow synthesis and PAT (process analytical technology), while small innovations in excipient selection and patient-friendly oral formulations aim to support adherence, and the integration of bioequivalence data with real-world evidence is increasingly important for approvals and market positioning.
Policy and industry drivers
Regulatory controls and narcotics scheduling are principal drivers shaping lisdexamfetamine’s market, as abuse-prevention measures, national production quotas, generic approval frameworks, pricing reforms and reimbursement decisions directly affect market access and price dynamics; conversely, emergency quota adjustments, incentives for domestic manufacturing and subsidies for local CDMO investment can reshape upstream supply and competitive dynamics.
This Insight Report provides a comprehensive analysis of the global Lisdexamfetamine Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Lisdexamfetamine Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Lisdexamfetamine Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Lisdexamfetamine Drug and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Lisdexamfetamine Drug.
This report presents a comprehensive overview, market shares, and growth opportunities of Lisdexamfetamine Drug market by product type, application, key manufacturers and key regions and countries.
Lisdexamfetamine is a central nervous system stimulant and a prodrug of dextroamphetamine, formed by combining dextroamphetamine with the amino acid lysine. It is primarily prescribed for the treatment of attention deficit hyperactivity disorder (ADHD) in children, adolescents, and adults, as well as for moderate to severe binge eating disorder in adults. Administered orally, it is metabolized into dextroamphetamine, with onset of action within about two hours and effects lasting up to 14 hours. In 2024, the global sales volume of lisdexamfetamine was 7.76 million units, with an average price of USD 459.9 per unit. The average gross margin of companies was 42.5%, and the annual production capacity of a single production line was 500,000 units.
Regional market landscape
The global market shows clear regional concentration with North America holding 45.2% of total volume, Europe 28.7%, Asia-Pacific 18.3%, Latin America 5.1%, and Middle East & Africa 2.7%; by formulation capsules represent 62.0% of global share, tablets 30.5% and oral solutions 7.5%, while distribution channels are split with hospitals and clinics accounting for 41.3% of demand, retail pharmacies 48.6% and other channels 10.1%, and these fixed regional and channel weights materially influence supply-chain planning, inventory strategy and market entry prioritization.
Key manufacturers and industry competition
The production and supply landscape for lisdexamfetamine is defined by competition between the originator and multiple generic manufacturers: Takeda remains the principal originator with substantial global rights, while generic producers have secured approvals and rapidly scaled capacity across markets; upstream, key chemical raw materials and API intermediates are typically supplied by large chemical firms and CDMOs (for example BASF, Lonza, Evonik and similar suppliers) together with packaging and capsule shell vendors, and downstream distribution is handled by hospitals, wholesalers and retail pharmacy networks, so due diligence must examine originator and generic capacity expansion plans, API sourcing and alternate supply channels, and downstream concentration to assess pricing elasticity and shortage risk.
Technology trends and innovation direction
Current technical trends emphasize improving formulation stability and content uniformity, refining bioequivalence and extended-release evaluation methods, and integrating tighter quality control and digital traceability into manufacturing; generics and CDMOs are reducing costs and improving consistency via process scale-up, continuous flow synthesis and PAT (process analytical technology), while small innovations in excipient selection and patient-friendly oral formulations aim to support adherence, and the integration of bioequivalence data with real-world evidence is increasingly important for approvals and market positioning.
Policy and industry drivers
Regulatory controls and narcotics scheduling are principal drivers shaping lisdexamfetamine’s market, as abuse-prevention measures, national production quotas, generic approval frameworks, pricing reforms and reimbursement decisions directly affect market access and price dynamics; conversely, emergency quota adjustments, incentives for domestic manufacturing and subsidies for local CDMO investment can reshape upstream supply and competitive dynamics.
Outlook
Over the coming years, as multiple generics scale and regulatory approvals broaden, the market is likely to see increased price pressure and diversified supply sources, though episodic regional shortages may persist due to upstream raw-material volatility or regulatory adjustments; for investors and acquirers, focus will shift from standalone financial performance toward robustness of API supply, redundancy in key packaging suppliers, stability of downstream distribution, and durable quality and compliance systems, with firms demonstrating strength across these dimensions positioned to gain competitive advantage.Report Scope
LP Information, Inc. (LPI) ' newest research report, the “Lisdexamfetamine Drug Industry Forecast” looks at past sales and reviews total world Lisdexamfetamine Drug sales in 2025, providing a comprehensive analysis by region and market sector of projected Lisdexamfetamine Drug sales for 2026 through 2032. With Lisdexamfetamine Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Lisdexamfetamine Drug industry.This Insight Report provides a comprehensive analysis of the global Lisdexamfetamine Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Lisdexamfetamine Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Lisdexamfetamine Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Lisdexamfetamine Drug and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Lisdexamfetamine Drug.
This report presents a comprehensive overview, market shares, and growth opportunities of Lisdexamfetamine Drug market by product type, application, key manufacturers and key regions and countries.
Market Segmentation
Segmentation by Type:
- Capsules
- Tablets
- Oral Solution
Segmentation by Application:
- Hospital and Clinic
- Retail Pharmacies
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Takeda Pharmaceutical
- Shionogi
- Aristo Pharma GmbH
- Sichuan Credit Pharmaceutical
- Huahai Pharmaceutical
- Hikma Pharmaceuticals
- Amneal Pharmaceuticals
- Sun Pharmaceutical Industries
- Teva Pharmaceutical
- Mylan
Key Questions Addressed in this Report
- What is the 10-year outlook for the global Lisdexamfetamine Drug market?
- What factors are driving Lisdexamfetamine Drug market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Lisdexamfetamine Drug market opportunities vary by end market size?
- How does Lisdexamfetamine Drug break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Lisdexamfetamine Drug Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Lisdexamfetamine Drug by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Lisdexamfetamine Drug by Country/Region, 2021, 2025 & 2032
2.2 Lisdexamfetamine Drug Segment by Type
2.2.1 Capsules
2.2.2 Tablets
2.2.3 Oral Solution
2.2.4 Lisdexamfetamine Drug Sales by Type
2.2.4.1 Global Lisdexamfetamine Drug Sales Market Share by Type (2021-2026)
2.2.4.2 Global Lisdexamfetamine Drug Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Lisdexamfetamine Drug Sale Price by Type (2021-2026)
2.3 Lisdexamfetamine Drug Segment by Application
2.3.1 Hospital and Clinic
2.3.2 Retail Pharmacies
2.3.3 Other
2.3.4 Lisdexamfetamine Drug Sales by Application
2.3.4.1 Global Lisdexamfetamine Drug Sale Market Share by Application (2021-2026)
2.3.4.2 Global Lisdexamfetamine Drug Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Lisdexamfetamine Drug Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Lisdexamfetamine Drug Breakdown Data by Company
3.1.1 Global Lisdexamfetamine Drug Annual Sales by Company (2021-2026)
3.1.2 Global Lisdexamfetamine Drug Sales Market Share by Company (2021-2026)
3.2 Global Lisdexamfetamine Drug Annual Revenue by Company (2021-2026)
3.2.1 Global Lisdexamfetamine Drug Revenue by Company (2021-2026)
3.2.2 Global Lisdexamfetamine Drug Revenue Market Share by Company (2021-2026)
3.3 Global Lisdexamfetamine Drug Sale Price by Company
3.4 Key Manufacturers Lisdexamfetamine Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Lisdexamfetamine Drug Product Location Distribution
3.4.2 Players Lisdexamfetamine Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR LISDEXAMFETAMINE DRUG BY GEOGRAPHIC REGION
4.1 World Historic Lisdexamfetamine Drug Market Size by Geographic Region (2021-2026)
4.1.1 Global Lisdexamfetamine Drug Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Lisdexamfetamine Drug Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Lisdexamfetamine Drug Market Size by Country/Region (2021-2026)
4.2.1 Global Lisdexamfetamine Drug Annual Sales by Country/Region (2021-2026)
4.2.2 Global Lisdexamfetamine Drug Annual Revenue by Country/Region (2021-2026)
4.3 Americas Lisdexamfetamine Drug Sales Growth
4.4 APAC Lisdexamfetamine Drug Sales Growth
4.5 Europe Lisdexamfetamine Drug Sales Growth
4.6 Middle East & Africa Lisdexamfetamine Drug Sales Growth
5 AMERICAS
5.1 Americas Lisdexamfetamine Drug Sales by Country
5.1.1 Americas Lisdexamfetamine Drug Sales by Country (2021-2026)
5.1.2 Americas Lisdexamfetamine Drug Revenue by Country (2021-2026)
5.2 Americas Lisdexamfetamine Drug Sales by Type (2021-2026)
5.3 Americas Lisdexamfetamine Drug Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Lisdexamfetamine Drug Sales by Region
6.1.1 APAC Lisdexamfetamine Drug Sales by Region (2021-2026)
6.1.2 APAC Lisdexamfetamine Drug Revenue by Region (2021-2026)
6.2 APAC Lisdexamfetamine Drug Sales by Type (2021-2026)
6.3 APAC Lisdexamfetamine Drug Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Lisdexamfetamine Drug by Country
7.1.1 Europe Lisdexamfetamine Drug Sales by Country (2021-2026)
7.1.2 Europe Lisdexamfetamine Drug Revenue by Country (2021-2026)
7.2 Europe Lisdexamfetamine Drug Sales by Type (2021-2026)
7.3 Europe Lisdexamfetamine Drug Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Lisdexamfetamine Drug by Country
8.1.1 Middle East & Africa Lisdexamfetamine Drug Sales by Country (2021-2026)
8.1.2 Middle East & Africa Lisdexamfetamine Drug Revenue by Country (2021-2026)
8.2 Middle East & Africa Lisdexamfetamine Drug Sales by Type (2021-2026)
8.3 Middle East & Africa Lisdexamfetamine Drug Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Lisdexamfetamine Drug
10.3 Manufacturing Process Analysis of Lisdexamfetamine Drug
10.4 Industry Chain Structure of Lisdexamfetamine Drug
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Lisdexamfetamine Drug Distributors
11.3 Lisdexamfetamine Drug Customer
12 WORLD FORECAST REVIEW FOR LISDEXAMFETAMINE DRUG BY GEOGRAPHIC REGION
12.1 Global Lisdexamfetamine Drug Market Size Forecast by Region
12.1.1 Global Lisdexamfetamine Drug Forecast by Region (2027-2032)
12.1.2 Global Lisdexamfetamine Drug Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Lisdexamfetamine Drug Forecast by Type (2027-2032)
12.7 Global Lisdexamfetamine Drug Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Takeda Pharmaceutical
13.1.1 Takeda Pharmaceutical Company Information
13.1.2 Takeda Pharmaceutical Lisdexamfetamine Drug Product Portfolios and Specifications
13.1.3 Takeda Pharmaceutical Lisdexamfetamine Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Takeda Pharmaceutical Main Business Overview
13.1.5 Takeda Pharmaceutical Latest Developments
13.2 Shionogi
13.2.1 Shionogi Company Information
13.2.2 Shionogi Lisdexamfetamine Drug Product Portfolios and Specifications
13.2.3 Shionogi Lisdexamfetamine Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Shionogi Main Business Overview
13.2.5 Shionogi Latest Developments
13.3 Aristo Pharma GmbH
13.3.1 Aristo Pharma GmbH Company Information
13.3.2 Aristo Pharma GmbH Lisdexamfetamine Drug Product Portfolios and Specifications
13.3.3 Aristo Pharma GmbH Lisdexamfetamine Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Aristo Pharma GmbH Main Business Overview
13.3.5 Aristo Pharma GmbH Latest Developments
13.4 Sichuan Credit Pharmaceutical
13.4.1 Sichuan Credit Pharmaceutical Company Information
13.4.2 Sichuan Credit Pharmaceutical Lisdexamfetamine Drug Product Portfolios and Specifications
13.4.3 Sichuan Credit Pharmaceutical Lisdexamfetamine Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Sichuan Credit Pharmaceutical Main Business Overview
13.4.5 Sichuan Credit Pharmaceutical Latest Developments
13.5 Huahai Pharmaceutical
13.5.1 Huahai Pharmaceutical Company Information
13.5.2 Huahai Pharmaceutical Lisdexamfetamine Drug Product Portfolios and Specifications
13.5.3 Huahai Pharmaceutical Lisdexamfetamine Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Huahai Pharmaceutical Main Business Overview
13.5.5 Huahai Pharmaceutical Latest Developments
13.6 Hikma Pharmaceuticals
13.6.1 Hikma Pharmaceuticals Company Information
13.6.2 Hikma Pharmaceuticals Lisdexamfetamine Drug Product Portfolios and Specifications
13.6.3 Hikma Pharmaceuticals Lisdexamfetamine Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Hikma Pharmaceuticals Main Business Overview
13.6.5 Hikma Pharmaceuticals Latest Developments
13.7 Amneal Pharmaceuticals
13.7.1 Amneal Pharmaceuticals Company Information
13.7.2 Amneal Pharmaceuticals Lisdexamfetamine Drug Product Portfolios and Specifications
13.7.3 Amneal Pharmaceuticals Lisdexamfetamine Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Amneal Pharmaceuticals Main Business Overview
13.7.5 Amneal Pharmaceuticals Latest Developments
13.8 Sun Pharmaceutical Industries
13.8.1 Sun Pharmaceutical Industries Company Information
13.8.2 Sun Pharmaceutical Industries Lisdexamfetamine Drug Product Portfolios and Specifications
13.8.3 Sun Pharmaceutical Industries Lisdexamfetamine Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Sun Pharmaceutical Industries Main Business Overview
13.8.5 Sun Pharmaceutical Industries Latest Developments
13.9 Teva Pharmaceutical
13.9.1 Teva Pharmaceutical Company Information
13.9.2 Teva Pharmaceutical Lisdexamfetamine Drug Product Portfolios and Specifications
13.9.3 Teva Pharmaceutical Lisdexamfetamine Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Teva Pharmaceutical Main Business Overview
13.9.5 Teva Pharmaceutical Latest Developments
13.10 Mylan
13.10.1 Mylan Company Information
13.10.2 Mylan Lisdexamfetamine Drug Product Portfolios and Specifications
13.10.3 Mylan Lisdexamfetamine Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Mylan Main Business Overview
13.10.5 Mylan Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Lisdexamfetamine Drug Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Lisdexamfetamine Drug by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Lisdexamfetamine Drug by Country/Region, 2021, 2025 & 2032
2.2 Lisdexamfetamine Drug Segment by Type
2.2.1 Capsules
2.2.2 Tablets
2.2.3 Oral Solution
2.2.4 Lisdexamfetamine Drug Sales by Type
2.2.4.1 Global Lisdexamfetamine Drug Sales Market Share by Type (2021-2026)
2.2.4.2 Global Lisdexamfetamine Drug Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Lisdexamfetamine Drug Sale Price by Type (2021-2026)
2.3 Lisdexamfetamine Drug Segment by Application
2.3.1 Hospital and Clinic
2.3.2 Retail Pharmacies
2.3.3 Other
2.3.4 Lisdexamfetamine Drug Sales by Application
2.3.4.1 Global Lisdexamfetamine Drug Sale Market Share by Application (2021-2026)
2.3.4.2 Global Lisdexamfetamine Drug Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Lisdexamfetamine Drug Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Lisdexamfetamine Drug Breakdown Data by Company
3.1.1 Global Lisdexamfetamine Drug Annual Sales by Company (2021-2026)
3.1.2 Global Lisdexamfetamine Drug Sales Market Share by Company (2021-2026)
3.2 Global Lisdexamfetamine Drug Annual Revenue by Company (2021-2026)
3.2.1 Global Lisdexamfetamine Drug Revenue by Company (2021-2026)
3.2.2 Global Lisdexamfetamine Drug Revenue Market Share by Company (2021-2026)
3.3 Global Lisdexamfetamine Drug Sale Price by Company
3.4 Key Manufacturers Lisdexamfetamine Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Lisdexamfetamine Drug Product Location Distribution
3.4.2 Players Lisdexamfetamine Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR LISDEXAMFETAMINE DRUG BY GEOGRAPHIC REGION
4.1 World Historic Lisdexamfetamine Drug Market Size by Geographic Region (2021-2026)
4.1.1 Global Lisdexamfetamine Drug Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Lisdexamfetamine Drug Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Lisdexamfetamine Drug Market Size by Country/Region (2021-2026)
4.2.1 Global Lisdexamfetamine Drug Annual Sales by Country/Region (2021-2026)
4.2.2 Global Lisdexamfetamine Drug Annual Revenue by Country/Region (2021-2026)
4.3 Americas Lisdexamfetamine Drug Sales Growth
4.4 APAC Lisdexamfetamine Drug Sales Growth
4.5 Europe Lisdexamfetamine Drug Sales Growth
4.6 Middle East & Africa Lisdexamfetamine Drug Sales Growth
5 AMERICAS
5.1 Americas Lisdexamfetamine Drug Sales by Country
5.1.1 Americas Lisdexamfetamine Drug Sales by Country (2021-2026)
5.1.2 Americas Lisdexamfetamine Drug Revenue by Country (2021-2026)
5.2 Americas Lisdexamfetamine Drug Sales by Type (2021-2026)
5.3 Americas Lisdexamfetamine Drug Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Lisdexamfetamine Drug Sales by Region
6.1.1 APAC Lisdexamfetamine Drug Sales by Region (2021-2026)
6.1.2 APAC Lisdexamfetamine Drug Revenue by Region (2021-2026)
6.2 APAC Lisdexamfetamine Drug Sales by Type (2021-2026)
6.3 APAC Lisdexamfetamine Drug Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Lisdexamfetamine Drug by Country
7.1.1 Europe Lisdexamfetamine Drug Sales by Country (2021-2026)
7.1.2 Europe Lisdexamfetamine Drug Revenue by Country (2021-2026)
7.2 Europe Lisdexamfetamine Drug Sales by Type (2021-2026)
7.3 Europe Lisdexamfetamine Drug Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Lisdexamfetamine Drug by Country
8.1.1 Middle East & Africa Lisdexamfetamine Drug Sales by Country (2021-2026)
8.1.2 Middle East & Africa Lisdexamfetamine Drug Revenue by Country (2021-2026)
8.2 Middle East & Africa Lisdexamfetamine Drug Sales by Type (2021-2026)
8.3 Middle East & Africa Lisdexamfetamine Drug Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Lisdexamfetamine Drug
10.3 Manufacturing Process Analysis of Lisdexamfetamine Drug
10.4 Industry Chain Structure of Lisdexamfetamine Drug
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Lisdexamfetamine Drug Distributors
11.3 Lisdexamfetamine Drug Customer
12 WORLD FORECAST REVIEW FOR LISDEXAMFETAMINE DRUG BY GEOGRAPHIC REGION
12.1 Global Lisdexamfetamine Drug Market Size Forecast by Region
12.1.1 Global Lisdexamfetamine Drug Forecast by Region (2027-2032)
12.1.2 Global Lisdexamfetamine Drug Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Lisdexamfetamine Drug Forecast by Type (2027-2032)
12.7 Global Lisdexamfetamine Drug Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Takeda Pharmaceutical
13.1.1 Takeda Pharmaceutical Company Information
13.1.2 Takeda Pharmaceutical Lisdexamfetamine Drug Product Portfolios and Specifications
13.1.3 Takeda Pharmaceutical Lisdexamfetamine Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Takeda Pharmaceutical Main Business Overview
13.1.5 Takeda Pharmaceutical Latest Developments
13.2 Shionogi
13.2.1 Shionogi Company Information
13.2.2 Shionogi Lisdexamfetamine Drug Product Portfolios and Specifications
13.2.3 Shionogi Lisdexamfetamine Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Shionogi Main Business Overview
13.2.5 Shionogi Latest Developments
13.3 Aristo Pharma GmbH
13.3.1 Aristo Pharma GmbH Company Information
13.3.2 Aristo Pharma GmbH Lisdexamfetamine Drug Product Portfolios and Specifications
13.3.3 Aristo Pharma GmbH Lisdexamfetamine Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Aristo Pharma GmbH Main Business Overview
13.3.5 Aristo Pharma GmbH Latest Developments
13.4 Sichuan Credit Pharmaceutical
13.4.1 Sichuan Credit Pharmaceutical Company Information
13.4.2 Sichuan Credit Pharmaceutical Lisdexamfetamine Drug Product Portfolios and Specifications
13.4.3 Sichuan Credit Pharmaceutical Lisdexamfetamine Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Sichuan Credit Pharmaceutical Main Business Overview
13.4.5 Sichuan Credit Pharmaceutical Latest Developments
13.5 Huahai Pharmaceutical
13.5.1 Huahai Pharmaceutical Company Information
13.5.2 Huahai Pharmaceutical Lisdexamfetamine Drug Product Portfolios and Specifications
13.5.3 Huahai Pharmaceutical Lisdexamfetamine Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Huahai Pharmaceutical Main Business Overview
13.5.5 Huahai Pharmaceutical Latest Developments
13.6 Hikma Pharmaceuticals
13.6.1 Hikma Pharmaceuticals Company Information
13.6.2 Hikma Pharmaceuticals Lisdexamfetamine Drug Product Portfolios and Specifications
13.6.3 Hikma Pharmaceuticals Lisdexamfetamine Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Hikma Pharmaceuticals Main Business Overview
13.6.5 Hikma Pharmaceuticals Latest Developments
13.7 Amneal Pharmaceuticals
13.7.1 Amneal Pharmaceuticals Company Information
13.7.2 Amneal Pharmaceuticals Lisdexamfetamine Drug Product Portfolios and Specifications
13.7.3 Amneal Pharmaceuticals Lisdexamfetamine Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Amneal Pharmaceuticals Main Business Overview
13.7.5 Amneal Pharmaceuticals Latest Developments
13.8 Sun Pharmaceutical Industries
13.8.1 Sun Pharmaceutical Industries Company Information
13.8.2 Sun Pharmaceutical Industries Lisdexamfetamine Drug Product Portfolios and Specifications
13.8.3 Sun Pharmaceutical Industries Lisdexamfetamine Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Sun Pharmaceutical Industries Main Business Overview
13.8.5 Sun Pharmaceutical Industries Latest Developments
13.9 Teva Pharmaceutical
13.9.1 Teva Pharmaceutical Company Information
13.9.2 Teva Pharmaceutical Lisdexamfetamine Drug Product Portfolios and Specifications
13.9.3 Teva Pharmaceutical Lisdexamfetamine Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Teva Pharmaceutical Main Business Overview
13.9.5 Teva Pharmaceutical Latest Developments
13.10 Mylan
13.10.1 Mylan Company Information
13.10.2 Mylan Lisdexamfetamine Drug Product Portfolios and Specifications
13.10.3 Mylan Lisdexamfetamine Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Mylan Main Business Overview
13.10.5 Mylan Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Lisdexamfetamine Drug Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Lisdexamfetamine Drug Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Capsules
Table 4. Major Players of Tablets
Table 5. Major Players of Oral Solution
Table 6. Global Lisdexamfetamine Drug Sales by Type (2021-2026) & (K Units)
Table 7. Global Lisdexamfetamine Drug Sales Market Share by Type (2021-2026)
Table 8. Global Lisdexamfetamine Drug Revenue by Type (2021-2026) & ($ million)
Table 9. Global Lisdexamfetamine Drug Revenue Market Share by Type (2021-2026)
Table 10. Global Lisdexamfetamine Drug Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Global Lisdexamfetamine Drug Sale by Application (2021-2026) & (K Units)
Table 12. Global Lisdexamfetamine Drug Sale Market Share by Application (2021-2026)
Table 13. Global Lisdexamfetamine Drug Revenue by Application (2021-2026) & ($ million)
Table 14. Global Lisdexamfetamine Drug Revenue Market Share by Application (2021-2026)
Table 15. Global Lisdexamfetamine Drug Sale Price by Application (2021-2026) & (US$/Unit)
Table 16. Global Lisdexamfetamine Drug Sales by Company (2021-2026) & (K Units)
Table 17. Global Lisdexamfetamine Drug Sales Market Share by Company (2021-2026)
Table 18. Global Lisdexamfetamine Drug Revenue by Company (2021-2026) & ($ millions)
Table 19. Global Lisdexamfetamine Drug Revenue Market Share by Company (2021-2026)
Table 20. Global Lisdexamfetamine Drug Sale Price by Company (2021-2026) & (US$/Unit)
Table 21. Key Manufacturers Lisdexamfetamine Drug Producing Area Distribution and Sales Area
Table 22. Players Lisdexamfetamine Drug Products Offered
Table 23. Lisdexamfetamine Drug Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Lisdexamfetamine Drug Sales by Geographic Region (2021-2026) & (K Units)
Table 27. Global Lisdexamfetamine Drug Sales Market Share Geographic Region (2021-2026)
Table 28. Global Lisdexamfetamine Drug Revenue by Geographic Region (2021-2026) & ($ millions)
Table 29. Global Lisdexamfetamine Drug Revenue Market Share by Geographic Region (2021-2026)
Table 30. Global Lisdexamfetamine Drug Sales by Country/Region (2021-2026) & (K Units)
Table 31. Global Lisdexamfetamine Drug Sales Market Share by Country/Region (2021-2026)
Table 32. Global Lisdexamfetamine Drug Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global Lisdexamfetamine Drug Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas Lisdexamfetamine Drug Sales by Country (2021-2026) & (K Units)
Table 35. Americas Lisdexamfetamine Drug Sales Market Share by Country (2021-2026)
Table 36. Americas Lisdexamfetamine Drug Revenue by Country (2021-2026) & ($ millions)
Table 37. Americas Lisdexamfetamine Drug Sales by Type (2021-2026) & (K Units)
Table 38. Americas Lisdexamfetamine Drug Sales by Application (2021-2026) & (K Units)
Table 39. APAC Lisdexamfetamine Drug Sales by Region (2021-2026) & (K Units)
Table 40. APAC Lisdexamfetamine Drug Sales Market Share by Region (2021-2026)
Table 41. APAC Lisdexamfetamine Drug Revenue by Region (2021-2026) & ($ millions)
Table 42. APAC Lisdexamfetamine Drug Sales by Type (2021-2026) & (K Units)
Table 43. APAC Lisdexamfetamine Drug Sales by Application (2021-2026) & (K Units)
Table 44. Europe Lisdexamfetamine Drug Sales by Country (2021-2026) & (K Units)
Table 45. Europe Lisdexamfetamine Drug Revenue by Country (2021-2026) & ($ millions)
Table 46. Europe Lisdexamfetamine Drug Sales by Type (2021-2026) & (K Units)
Table 47. Europe Lisdexamfetamine Drug Sales by Application (2021-2026) & (K Units)
Table 48. Middle East & Africa Lisdexamfetamine Drug Sales by Country (2021-2026) & (K Units)
Table 49. Middle East & Africa Lisdexamfetamine Drug Revenue Market Share by Country (2021-2026)
Table 50. Middle East & Africa Lisdexamfetamine Drug Sales by Type (2021-2026) & (K Units)
Table 51. Middle East & Africa Lisdexamfetamine Drug Sales by Application (2021-2026) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of Lisdexamfetamine Drug
Table 53. Key Market Challenges & Risks of Lisdexamfetamine Drug
Table 54. Key Industry Trends of Lisdexamfetamine Drug
Table 55. Lisdexamfetamine Drug Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Lisdexamfetamine Drug Distributors List
Table 58. Lisdexamfetamine Drug Customer List
Table 59. Global Lisdexamfetamine Drug Sales Forecast by Region (2027-2032) & (K Units)
Table 60. Global Lisdexamfetamine Drug Revenue Forecast by Region (2027-2032) & ($ millions)
Table 61. Americas Lisdexamfetamine Drug Sales Forecast by Country (2027-2032) & (K Units)
Table 62. Americas Lisdexamfetamine Drug Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 63. APAC Lisdexamfetamine Drug Sales Forecast by Region (2027-2032) & (K Units)
Table 64. APAC Lisdexamfetamine Drug Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 65. Europe Lisdexamfetamine Drug Sales Forecast by Country (2027-2032) & (K Units)
Table 66. Europe Lisdexamfetamine Drug Revenue Forecast by Country (2027-2032) & ($ millions)
Table 67. Middle East & Africa Lisdexamfetamine Drug Sales Forecast by Country (2027-2032) & (K Units)
Table 68. Middle East & Africa Lisdexamfetamine Drug Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Global Lisdexamfetamine Drug Sales Forecast by Type (2027-2032) & (K Units)
Table 70. Global Lisdexamfetamine Drug Revenue Forecast by Type (2027-2032) & ($ millions)
Table 71. Global Lisdexamfetamine Drug Sales Forecast by Application (2027-2032) & (K Units)
Table 72. Global Lisdexamfetamine Drug Revenue Forecast by Application (2027-2032) & ($ millions)
Table 73. Takeda Pharmaceutical Basic Information, Lisdexamfetamine Drug Manufacturing Base, Sales Area and Its Competitors
Table 74. Takeda Pharmaceutical Lisdexamfetamine Drug Product Portfolios and Specifications
Table 75. Takeda Pharmaceutical Lisdexamfetamine Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 76. Takeda Pharmaceutical Main Business
Table 77. Takeda Pharmaceutical Latest Developments
Table 78. Shionogi Basic Information, Lisdexamfetamine Drug Manufacturing Base, Sales Area and Its Competitors
Table 79. Shionogi Lisdexamfetamine Drug Product Portfolios and Specifications
Table 80. Shionogi Lisdexamfetamine Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 81. Shionogi Main Business
Table 82. Shionogi Latest Developments
Table 83. Aristo Pharma GmbH Basic Information, Lisdexamfetamine Drug Manufacturing Base, Sales Area and Its Competitors
Table 84. Aristo Pharma GmbH Lisdexamfetamine Drug Product Portfolios and Specifications
Table 85. Aristo Pharma GmbH Lisdexamfetamine Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 86. Aristo Pharma GmbH Main Business
Table 87. Aristo Pharma GmbH Latest Developments
Table 88. Sichuan Credit Pharmaceutical Basic Information, Lisdexamfetamine Drug Manufacturing Base, Sales Area and Its Competitors
Table 89. Sichuan Credit Pharmaceutical Lisdexamfetamine Drug Product Portfolios and Specifications
Table 90. Sichuan Credit Pharmaceutical Lisdexamfetamine Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. Sichuan Credit Pharmaceutical Main Business
Table 92. Sichuan Credit Pharmaceutical Latest Developments
Table 93. Huahai Pharmaceutical Basic Information, Lisdexamfetamine Drug Manufacturing Base, Sales Area and Its Competitors
Table 94. Huahai Pharmaceutical Lisdexamfetamine Drug Product Portfolios and Specifications
Table 95. Huahai Pharmaceutical Lisdexamfetamine Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. Huahai Pharmaceutical Main Business
Table 97. Huahai Pharmaceutical Latest Developments
Table 98. Hikma Pharmaceuticals Basic Information, Lisdexamfetamine Drug Manufacturing Base, Sales Area and Its Competitors
Table 99. Hikma Pharmaceuticals Lisdexamfetamine Drug Product Portfolios and Specifications
Table 100. Hikma Pharmaceuticals Lisdexamfetamine Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. Hikma Pharmaceuticals Main Business
Table 102. Hikma Pharmaceuticals Latest Developments
Table 103. Amneal Pharmaceuticals Basic Information, Lisdexamfetamine Drug Manufacturing Base, Sales Area and Its Competitors
Table 104. Amneal Pharmaceuticals Lisdexamfetamine Drug Product Portfolios and Specifications
Table 105. Amneal Pharmaceuticals Lisdexamfetamine Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 106. Amneal Pharmaceuticals Main Business
Table 107. Amneal Pharmaceuticals Latest Developments
Table 108. Sun Pharmaceutical Industries Basic Information, Lisdexamfetamine Drug Manufacturing Base, Sales Area and Its Competitors
Table 109. Sun Pharmaceutical Industries Lisdexamfetamine Drug Product Portfolios and Specifications
Table 110. Sun Pharmaceutical Industries Lisdexamfetamine Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 111. Sun Pharmaceutical Industries Main Business
Table 112. Sun Pharmaceutical Industries Latest Developments
Table 113. Teva Pharmaceutical Basic Information, Lisdexamfetamine Drug Manufacturing Base, Sales Area and Its Competitors
Table 114. Teva Pharmaceutical Lisdexamfetamine Drug Product Portfolios and Specifications
Table 115. Teva Pharmaceutical Lisdexamfetamine Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 116. Teva Pharmaceutical Main Business
Table 117. Teva Pharmaceutical Latest Developments
Table 118. Mylan Basic Information, Lisdexamfetamine Drug Manufacturing Base, Sales Area and Its Competitors
Table 119. Mylan Lisdexamfetamine Drug Product Portfolios and Specifications
Table 120. Mylan Lisdexamfetamine Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 121. Mylan Main Business
Table 122. Mylan Latest Developments
Table 1. Lisdexamfetamine Drug Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Lisdexamfetamine Drug Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Capsules
Table 4. Major Players of Tablets
Table 5. Major Players of Oral Solution
Table 6. Global Lisdexamfetamine Drug Sales by Type (2021-2026) & (K Units)
Table 7. Global Lisdexamfetamine Drug Sales Market Share by Type (2021-2026)
Table 8. Global Lisdexamfetamine Drug Revenue by Type (2021-2026) & ($ million)
Table 9. Global Lisdexamfetamine Drug Revenue Market Share by Type (2021-2026)
Table 10. Global Lisdexamfetamine Drug Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Global Lisdexamfetamine Drug Sale by Application (2021-2026) & (K Units)
Table 12. Global Lisdexamfetamine Drug Sale Market Share by Application (2021-2026)
Table 13. Global Lisdexamfetamine Drug Revenue by Application (2021-2026) & ($ million)
Table 14. Global Lisdexamfetamine Drug Revenue Market Share by Application (2021-2026)
Table 15. Global Lisdexamfetamine Drug Sale Price by Application (2021-2026) & (US$/Unit)
Table 16. Global Lisdexamfetamine Drug Sales by Company (2021-2026) & (K Units)
Table 17. Global Lisdexamfetamine Drug Sales Market Share by Company (2021-2026)
Table 18. Global Lisdexamfetamine Drug Revenue by Company (2021-2026) & ($ millions)
Table 19. Global Lisdexamfetamine Drug Revenue Market Share by Company (2021-2026)
Table 20. Global Lisdexamfetamine Drug Sale Price by Company (2021-2026) & (US$/Unit)
Table 21. Key Manufacturers Lisdexamfetamine Drug Producing Area Distribution and Sales Area
Table 22. Players Lisdexamfetamine Drug Products Offered
Table 23. Lisdexamfetamine Drug Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Lisdexamfetamine Drug Sales by Geographic Region (2021-2026) & (K Units)
Table 27. Global Lisdexamfetamine Drug Sales Market Share Geographic Region (2021-2026)
Table 28. Global Lisdexamfetamine Drug Revenue by Geographic Region (2021-2026) & ($ millions)
Table 29. Global Lisdexamfetamine Drug Revenue Market Share by Geographic Region (2021-2026)
Table 30. Global Lisdexamfetamine Drug Sales by Country/Region (2021-2026) & (K Units)
Table 31. Global Lisdexamfetamine Drug Sales Market Share by Country/Region (2021-2026)
Table 32. Global Lisdexamfetamine Drug Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global Lisdexamfetamine Drug Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas Lisdexamfetamine Drug Sales by Country (2021-2026) & (K Units)
Table 35. Americas Lisdexamfetamine Drug Sales Market Share by Country (2021-2026)
Table 36. Americas Lisdexamfetamine Drug Revenue by Country (2021-2026) & ($ millions)
Table 37. Americas Lisdexamfetamine Drug Sales by Type (2021-2026) & (K Units)
Table 38. Americas Lisdexamfetamine Drug Sales by Application (2021-2026) & (K Units)
Table 39. APAC Lisdexamfetamine Drug Sales by Region (2021-2026) & (K Units)
Table 40. APAC Lisdexamfetamine Drug Sales Market Share by Region (2021-2026)
Table 41. APAC Lisdexamfetamine Drug Revenue by Region (2021-2026) & ($ millions)
Table 42. APAC Lisdexamfetamine Drug Sales by Type (2021-2026) & (K Units)
Table 43. APAC Lisdexamfetamine Drug Sales by Application (2021-2026) & (K Units)
Table 44. Europe Lisdexamfetamine Drug Sales by Country (2021-2026) & (K Units)
Table 45. Europe Lisdexamfetamine Drug Revenue by Country (2021-2026) & ($ millions)
Table 46. Europe Lisdexamfetamine Drug Sales by Type (2021-2026) & (K Units)
Table 47. Europe Lisdexamfetamine Drug Sales by Application (2021-2026) & (K Units)
Table 48. Middle East & Africa Lisdexamfetamine Drug Sales by Country (2021-2026) & (K Units)
Table 49. Middle East & Africa Lisdexamfetamine Drug Revenue Market Share by Country (2021-2026)
Table 50. Middle East & Africa Lisdexamfetamine Drug Sales by Type (2021-2026) & (K Units)
Table 51. Middle East & Africa Lisdexamfetamine Drug Sales by Application (2021-2026) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of Lisdexamfetamine Drug
Table 53. Key Market Challenges & Risks of Lisdexamfetamine Drug
Table 54. Key Industry Trends of Lisdexamfetamine Drug
Table 55. Lisdexamfetamine Drug Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Lisdexamfetamine Drug Distributors List
Table 58. Lisdexamfetamine Drug Customer List
Table 59. Global Lisdexamfetamine Drug Sales Forecast by Region (2027-2032) & (K Units)
Table 60. Global Lisdexamfetamine Drug Revenue Forecast by Region (2027-2032) & ($ millions)
Table 61. Americas Lisdexamfetamine Drug Sales Forecast by Country (2027-2032) & (K Units)
Table 62. Americas Lisdexamfetamine Drug Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 63. APAC Lisdexamfetamine Drug Sales Forecast by Region (2027-2032) & (K Units)
Table 64. APAC Lisdexamfetamine Drug Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 65. Europe Lisdexamfetamine Drug Sales Forecast by Country (2027-2032) & (K Units)
Table 66. Europe Lisdexamfetamine Drug Revenue Forecast by Country (2027-2032) & ($ millions)
Table 67. Middle East & Africa Lisdexamfetamine Drug Sales Forecast by Country (2027-2032) & (K Units)
Table 68. Middle East & Africa Lisdexamfetamine Drug Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Global Lisdexamfetamine Drug Sales Forecast by Type (2027-2032) & (K Units)
Table 70. Global Lisdexamfetamine Drug Revenue Forecast by Type (2027-2032) & ($ millions)
Table 71. Global Lisdexamfetamine Drug Sales Forecast by Application (2027-2032) & (K Units)
Table 72. Global Lisdexamfetamine Drug Revenue Forecast by Application (2027-2032) & ($ millions)
Table 73. Takeda Pharmaceutical Basic Information, Lisdexamfetamine Drug Manufacturing Base, Sales Area and Its Competitors
Table 74. Takeda Pharmaceutical Lisdexamfetamine Drug Product Portfolios and Specifications
Table 75. Takeda Pharmaceutical Lisdexamfetamine Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 76. Takeda Pharmaceutical Main Business
Table 77. Takeda Pharmaceutical Latest Developments
Table 78. Shionogi Basic Information, Lisdexamfetamine Drug Manufacturing Base, Sales Area and Its Competitors
Table 79. Shionogi Lisdexamfetamine Drug Product Portfolios and Specifications
Table 80. Shionogi Lisdexamfetamine Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 81. Shionogi Main Business
Table 82. Shionogi Latest Developments
Table 83. Aristo Pharma GmbH Basic Information, Lisdexamfetamine Drug Manufacturing Base, Sales Area and Its Competitors
Table 84. Aristo Pharma GmbH Lisdexamfetamine Drug Product Portfolios and Specifications
Table 85. Aristo Pharma GmbH Lisdexamfetamine Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 86. Aristo Pharma GmbH Main Business
Table 87. Aristo Pharma GmbH Latest Developments
Table 88. Sichuan Credit Pharmaceutical Basic Information, Lisdexamfetamine Drug Manufacturing Base, Sales Area and Its Competitors
Table 89. Sichuan Credit Pharmaceutical Lisdexamfetamine Drug Product Portfolios and Specifications
Table 90. Sichuan Credit Pharmaceutical Lisdexamfetamine Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. Sichuan Credit Pharmaceutical Main Business
Table 92. Sichuan Credit Pharmaceutical Latest Developments
Table 93. Huahai Pharmaceutical Basic Information, Lisdexamfetamine Drug Manufacturing Base, Sales Area and Its Competitors
Table 94. Huahai Pharmaceutical Lisdexamfetamine Drug Product Portfolios and Specifications
Table 95. Huahai Pharmaceutical Lisdexamfetamine Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. Huahai Pharmaceutical Main Business
Table 97. Huahai Pharmaceutical Latest Developments
Table 98. Hikma Pharmaceuticals Basic Information, Lisdexamfetamine Drug Manufacturing Base, Sales Area and Its Competitors
Table 99. Hikma Pharmaceuticals Lisdexamfetamine Drug Product Portfolios and Specifications
Table 100. Hikma Pharmaceuticals Lisdexamfetamine Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. Hikma Pharmaceuticals Main Business
Table 102. Hikma Pharmaceuticals Latest Developments
Table 103. Amneal Pharmaceuticals Basic Information, Lisdexamfetamine Drug Manufacturing Base, Sales Area and Its Competitors
Table 104. Amneal Pharmaceuticals Lisdexamfetamine Drug Product Portfolios and Specifications
Table 105. Amneal Pharmaceuticals Lisdexamfetamine Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 106. Amneal Pharmaceuticals Main Business
Table 107. Amneal Pharmaceuticals Latest Developments
Table 108. Sun Pharmaceutical Industries Basic Information, Lisdexamfetamine Drug Manufacturing Base, Sales Area and Its Competitors
Table 109. Sun Pharmaceutical Industries Lisdexamfetamine Drug Product Portfolios and Specifications
Table 110. Sun Pharmaceutical Industries Lisdexamfetamine Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 111. Sun Pharmaceutical Industries Main Business
Table 112. Sun Pharmaceutical Industries Latest Developments
Table 113. Teva Pharmaceutical Basic Information, Lisdexamfetamine Drug Manufacturing Base, Sales Area and Its Competitors
Table 114. Teva Pharmaceutical Lisdexamfetamine Drug Product Portfolios and Specifications
Table 115. Teva Pharmaceutical Lisdexamfetamine Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 116. Teva Pharmaceutical Main Business
Table 117. Teva Pharmaceutical Latest Developments
Table 118. Mylan Basic Information, Lisdexamfetamine Drug Manufacturing Base, Sales Area and Its Competitors
Table 119. Mylan Lisdexamfetamine Drug Product Portfolios and Specifications
Table 120. Mylan Lisdexamfetamine Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 121. Mylan Main Business
Table 122. Mylan Latest Developments
LIST OF FIGURES
Figure 1. Picture of Lisdexamfetamine Drug
Figure 2. Lisdexamfetamine Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Lisdexamfetamine Drug Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Lisdexamfetamine Drug Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Lisdexamfetamine Drug Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Lisdexamfetamine Drug Sales Market Share by Country/Region (2025)
Figure 10. Lisdexamfetamine Drug Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Capsules
Figure 12. Product Picture of Tablets
Figure 13. Product Picture of Oral Solution
Figure 14. Global Lisdexamfetamine Drug Sales Market Share by Type in 2026
Figure 15. Global Lisdexamfetamine Drug Revenue Market Share by Type (2021-2026)
Figure 16. Lisdexamfetamine Drug Consumed in Hospital and Clinic
Figure 17. Global Lisdexamfetamine Drug Market: Hospital and Clinic (2021-2026) & (K Units)
Figure 18. Lisdexamfetamine Drug Consumed in Retail Pharmacies
Figure 19. Global Lisdexamfetamine Drug Market: Retail Pharmacies (2021-2026) & (K Units)
Figure 20. Lisdexamfetamine Drug Consumed in Other
Figure 21. Global Lisdexamfetamine Drug Market: Other (2021-2026) & (K Units)
Figure 22. Global Lisdexamfetamine Drug Sale Market Share by Application (2025)
Figure 23. Global Lisdexamfetamine Drug Revenue Market Share by Application in 2026
Figure 24. Lisdexamfetamine Drug Sales by Company in 2026 (K Units)
Figure 25. Global Lisdexamfetamine Drug Sales Market Share by Company in 2026
Figure 26. Lisdexamfetamine Drug Revenue by Company in 2026 ($ millions)
Figure 27. Global Lisdexamfetamine Drug Revenue Market Share by Company in 2026
Figure 28. Global Lisdexamfetamine Drug Sales Market Share by Geographic Region (2021-2026)
Figure 29. Global Lisdexamfetamine Drug Revenue Market Share by Geographic Region in 2026
Figure 30. Americas Lisdexamfetamine Drug Sales 2021-2026 (K Units)
Figure 31. Americas Lisdexamfetamine Drug Revenue 2021-2026 ($ millions)
Figure 32. APAC Lisdexamfetamine Drug Sales 2021-2026 (K Units)
Figure 33. APAC Lisdexamfetamine Drug Revenue 2021-2026 ($ millions)
Figure 34. Europe Lisdexamfetamine Drug Sales 2021-2026 (K Units)
Figure 35. Europe Lisdexamfetamine Drug Revenue 2021-2026 ($ millions)
Figure 36. Middle East & Africa Lisdexamfetamine Drug Sales 2021-2026 (K Units)
Figure 37. Middle East & Africa Lisdexamfetamine Drug Revenue 2021-2026 ($ millions)
Figure 38. Americas Lisdexamfetamine Drug Sales Market Share by Country in 2026
Figure 39. Americas Lisdexamfetamine Drug Revenue Market Share by Country (2021-2026)
Figure 40. Americas Lisdexamfetamine Drug Sales Market Share by Type (2021-2026)
Figure 41. Americas Lisdexamfetamine Drug Sales Market Share by Application (2021-2026)
Figure 42. United States Lisdexamfetamine Drug Revenue Growth 2021-2026 ($ millions)
Figure 43. Canada Lisdexamfetamine Drug Revenue Growth 2021-2026 ($ millions)
Figure 44. Mexico Lisdexamfetamine Drug Revenue Growth 2021-2026 ($ millions)
Figure 45. Brazil Lisdexamfetamine Drug Revenue Growth 2021-2026 ($ millions)
Figure 46. APAC Lisdexamfetamine Drug Sales Market Share by Region in 2026
Figure 47. APAC Lisdexamfetamine Drug Revenue Market Share by Region (2021-2026)
Figure 48. APAC Lisdexamfetamine Drug Sales Market Share by Type (2021-2026)
Figure 49. APAC Lisdexamfetamine Drug Sales Market Share by Application (2021-2026)
Figure 50. China Lisdexamfetamine Drug Revenue Growth 2021-2026 ($ millions)
Figure 51. Japan Lisdexamfetamine Drug Revenue Growth 2021-2026 ($ millions)
Figure 52. South Korea Lisdexamfetamine Drug Revenue Growth 2021-2026 ($ millions)
Figure 53. Southeast Asia Lisdexamfetamine Drug Revenue Growth 2021-2026 ($ millions)
Figure 54. India Lisdexamfetamine Drug Revenue Growth 2021-2026 ($ millions)
Figure 55. Australia Lisdexamfetamine Drug Revenue Growth 2021-2026 ($ millions)
Figure 56. China Taiwan Lisdexamfetamine Drug Revenue Growth 2021-2026 ($ millions)
Figure 57. Europe Lisdexamfetamine Drug Sales Market Share by Country in 2026
Figure 58. Europe Lisdexamfetamine Drug Revenue Market Share by Country (2021-2026)
Figure 59. Europe Lisdexamfetamine Drug Sales Market Share by Type (2021-2026)
Figure 60. Europe Lisdexamfetamine Drug Sales Market Share by Application (2021-2026)
Figure 61. Germany Lisdexamfetamine Drug Revenue Growth 2021-2026 ($ millions)
Figure 62. France Lisdexamfetamine Drug Revenue Growth 2021-2026 ($ millions)
Figure 63. UK Lisdexamfetamine Drug Revenue Growth 2021-2026 ($ millions)
Figure 64. Italy Lisdexamfetamine Drug Revenue Growth 2021-2026 ($ millions)
Figure 65. Russia Lisdexamfetamine Drug Revenue Growth 2021-2026 ($ millions)
Figure 66. Middle East & Africa Lisdexamfetamine Drug Sales Market Share by Country (2021-2026)
Figure 67. Middle East & Africa Lisdexamfetamine Drug Sales Market Share by Type (2021-2026)
Figure 68. Middle East & Africa Lisdexamfetamine Drug Sales Market Share by Application (2021-2026)
Figure 69. Egypt Lisdexamfetamine Drug Revenue Growth 2021-2026 ($ millions)
Figure 70. South Africa Lisdexamfetamine Drug Revenue Growth 2021-2026 ($ millions)
Figure 71. Israel Lisdexamfetamine Drug Revenue Growth 2021-2026 ($ millions)
Figure 72. Turkey Lisdexamfetamine Drug Revenue Growth 2021-2026 ($ millions)
Figure 73. GCC Countries Lisdexamfetamine Drug Revenue Growth 2021-2026 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Lisdexamfetamine Drug in 2026
Figure 75. Manufacturing Process Analysis of Lisdexamfetamine Drug
Figure 76. Industry Chain Structure of Lisdexamfetamine Drug
Figure 77. Channels of Distribution
Figure 78. Global Lisdexamfetamine Drug Sales Market Forecast by Region (2027-2032)
Figure 79. Global Lisdexamfetamine Drug Revenue Market Share Forecast by Region (2027-2032)
Figure 80. Global Lisdexamfetamine Drug Sales Market Share Forecast by Type (2027-2032)
Figure 81. Global Lisdexamfetamine Drug Revenue Market Share Forecast by Type (2027-2032)
Figure 82. Global Lisdexamfetamine Drug Sales Market Share Forecast by Application (2027-2032)
Figure 83. Global Lisdexamfetamine Drug Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Lisdexamfetamine Drug
Figure 2. Lisdexamfetamine Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Lisdexamfetamine Drug Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Lisdexamfetamine Drug Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Lisdexamfetamine Drug Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Lisdexamfetamine Drug Sales Market Share by Country/Region (2025)
Figure 10. Lisdexamfetamine Drug Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Capsules
Figure 12. Product Picture of Tablets
Figure 13. Product Picture of Oral Solution
Figure 14. Global Lisdexamfetamine Drug Sales Market Share by Type in 2026
Figure 15. Global Lisdexamfetamine Drug Revenue Market Share by Type (2021-2026)
Figure 16. Lisdexamfetamine Drug Consumed in Hospital and Clinic
Figure 17. Global Lisdexamfetamine Drug Market: Hospital and Clinic (2021-2026) & (K Units)
Figure 18. Lisdexamfetamine Drug Consumed in Retail Pharmacies
Figure 19. Global Lisdexamfetamine Drug Market: Retail Pharmacies (2021-2026) & (K Units)
Figure 20. Lisdexamfetamine Drug Consumed in Other
Figure 21. Global Lisdexamfetamine Drug Market: Other (2021-2026) & (K Units)
Figure 22. Global Lisdexamfetamine Drug Sale Market Share by Application (2025)
Figure 23. Global Lisdexamfetamine Drug Revenue Market Share by Application in 2026
Figure 24. Lisdexamfetamine Drug Sales by Company in 2026 (K Units)
Figure 25. Global Lisdexamfetamine Drug Sales Market Share by Company in 2026
Figure 26. Lisdexamfetamine Drug Revenue by Company in 2026 ($ millions)
Figure 27. Global Lisdexamfetamine Drug Revenue Market Share by Company in 2026
Figure 28. Global Lisdexamfetamine Drug Sales Market Share by Geographic Region (2021-2026)
Figure 29. Global Lisdexamfetamine Drug Revenue Market Share by Geographic Region in 2026
Figure 30. Americas Lisdexamfetamine Drug Sales 2021-2026 (K Units)
Figure 31. Americas Lisdexamfetamine Drug Revenue 2021-2026 ($ millions)
Figure 32. APAC Lisdexamfetamine Drug Sales 2021-2026 (K Units)
Figure 33. APAC Lisdexamfetamine Drug Revenue 2021-2026 ($ millions)
Figure 34. Europe Lisdexamfetamine Drug Sales 2021-2026 (K Units)
Figure 35. Europe Lisdexamfetamine Drug Revenue 2021-2026 ($ millions)
Figure 36. Middle East & Africa Lisdexamfetamine Drug Sales 2021-2026 (K Units)
Figure 37. Middle East & Africa Lisdexamfetamine Drug Revenue 2021-2026 ($ millions)
Figure 38. Americas Lisdexamfetamine Drug Sales Market Share by Country in 2026
Figure 39. Americas Lisdexamfetamine Drug Revenue Market Share by Country (2021-2026)
Figure 40. Americas Lisdexamfetamine Drug Sales Market Share by Type (2021-2026)
Figure 41. Americas Lisdexamfetamine Drug Sales Market Share by Application (2021-2026)
Figure 42. United States Lisdexamfetamine Drug Revenue Growth 2021-2026 ($ millions)
Figure 43. Canada Lisdexamfetamine Drug Revenue Growth 2021-2026 ($ millions)
Figure 44. Mexico Lisdexamfetamine Drug Revenue Growth 2021-2026 ($ millions)
Figure 45. Brazil Lisdexamfetamine Drug Revenue Growth 2021-2026 ($ millions)
Figure 46. APAC Lisdexamfetamine Drug Sales Market Share by Region in 2026
Figure 47. APAC Lisdexamfetamine Drug Revenue Market Share by Region (2021-2026)
Figure 48. APAC Lisdexamfetamine Drug Sales Market Share by Type (2021-2026)
Figure 49. APAC Lisdexamfetamine Drug Sales Market Share by Application (2021-2026)
Figure 50. China Lisdexamfetamine Drug Revenue Growth 2021-2026 ($ millions)
Figure 51. Japan Lisdexamfetamine Drug Revenue Growth 2021-2026 ($ millions)
Figure 52. South Korea Lisdexamfetamine Drug Revenue Growth 2021-2026 ($ millions)
Figure 53. Southeast Asia Lisdexamfetamine Drug Revenue Growth 2021-2026 ($ millions)
Figure 54. India Lisdexamfetamine Drug Revenue Growth 2021-2026 ($ millions)
Figure 55. Australia Lisdexamfetamine Drug Revenue Growth 2021-2026 ($ millions)
Figure 56. China Taiwan Lisdexamfetamine Drug Revenue Growth 2021-2026 ($ millions)
Figure 57. Europe Lisdexamfetamine Drug Sales Market Share by Country in 2026
Figure 58. Europe Lisdexamfetamine Drug Revenue Market Share by Country (2021-2026)
Figure 59. Europe Lisdexamfetamine Drug Sales Market Share by Type (2021-2026)
Figure 60. Europe Lisdexamfetamine Drug Sales Market Share by Application (2021-2026)
Figure 61. Germany Lisdexamfetamine Drug Revenue Growth 2021-2026 ($ millions)
Figure 62. France Lisdexamfetamine Drug Revenue Growth 2021-2026 ($ millions)
Figure 63. UK Lisdexamfetamine Drug Revenue Growth 2021-2026 ($ millions)
Figure 64. Italy Lisdexamfetamine Drug Revenue Growth 2021-2026 ($ millions)
Figure 65. Russia Lisdexamfetamine Drug Revenue Growth 2021-2026 ($ millions)
Figure 66. Middle East & Africa Lisdexamfetamine Drug Sales Market Share by Country (2021-2026)
Figure 67. Middle East & Africa Lisdexamfetamine Drug Sales Market Share by Type (2021-2026)
Figure 68. Middle East & Africa Lisdexamfetamine Drug Sales Market Share by Application (2021-2026)
Figure 69. Egypt Lisdexamfetamine Drug Revenue Growth 2021-2026 ($ millions)
Figure 70. South Africa Lisdexamfetamine Drug Revenue Growth 2021-2026 ($ millions)
Figure 71. Israel Lisdexamfetamine Drug Revenue Growth 2021-2026 ($ millions)
Figure 72. Turkey Lisdexamfetamine Drug Revenue Growth 2021-2026 ($ millions)
Figure 73. GCC Countries Lisdexamfetamine Drug Revenue Growth 2021-2026 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Lisdexamfetamine Drug in 2026
Figure 75. Manufacturing Process Analysis of Lisdexamfetamine Drug
Figure 76. Industry Chain Structure of Lisdexamfetamine Drug
Figure 77. Channels of Distribution
Figure 78. Global Lisdexamfetamine Drug Sales Market Forecast by Region (2027-2032)
Figure 79. Global Lisdexamfetamine Drug Revenue Market Share Forecast by Region (2027-2032)
Figure 80. Global Lisdexamfetamine Drug Sales Market Share Forecast by Type (2027-2032)
Figure 81. Global Lisdexamfetamine Drug Revenue Market Share Forecast by Type (2027-2032)
Figure 82. Global Lisdexamfetamine Drug Sales Market Share Forecast by Application (2027-2032)
Figure 83. Global Lisdexamfetamine Drug Revenue Market Share Forecast by Application (2027-2032)
